Full Press Release Details
IRVINE, Calif. , Aug. 5, 2025 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV ), is launching its Faces of Natrelle ® campaign – a powerful tribute to resilience and authenticity. The campaign features nine inspiring women who openly share their breast augmentation and reconstruction journeys with Natrelle ® breast implants, aiming to reshape the narrative around breast procedures through real, relatable stories.
Following a nationwide open casting call earlier this year, the selected women represent a wide range of lived experiences – from navigating reconstruction after breast cancer, to reclaiming their body after motherhood, or simply choosing to invest in themselves. United by strength and a renewed sense of self, these women embody the Natrelle ® mission: embrace your journey, own your choices, and live your curves.
Meet the 2025 Faces of Natrelle ® :
The Faces of Natrelle ® will be featured on the brand's social media channels and all relevant digital platforms. To learn more about the campaign and the women's stories or find information on Natrelle ® breast implants, visit www.natrelle.com or follow @NatrelleBreastAugmentation and @NatrelleBreastReconstruction on Instagram, @natrelle on YouTube, and @natrellebreastimplants on TikTok. Natrelle ® offers the broadest selection of breast implant options – with 300 options, five profiles, and three gel types – allowing patients and surgeons to achieve their desired look.
Natrelle ® Breast Implants IMPORTANT SAFETY INFORMATION AND APPROVED USES
Breast implants are not considered lifetime devices. The longer people have them, the greater the chances are that they will develop complications, some of which will require more surgery.
Breast implants have been associated with the development of a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). This cancer occurs more commonly in patients with textured breast implants than smooth implants, although rates are not well defined. Some patients have died from BIA-ALCL.
Patients receiving breast implants have reported a variety of systemic symptoms, such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others. Individual patient risk for developing these symptoms has not been well established. Some patients report complete resolution of symptoms when the implants are removed without replacement.
Who can get breast implants? Natrelle ® Breast Implants are approved for the following:
Who should NOT get breast implants? Breast implant surgery should NOT be performed in:
What should I tell my doctor? Tell your doctor if you have any of the following conditions, as the risks of breast implant surgery may be higher:
What else should I consider?
What are key complications with breast implants? Key complications include reoperation, implant removal with or without replacement, implant rupture with silicone-filled implants, implant deflation with saline-filled implants, and capsular contracture (severe scar tissue around the implant). Other complications include breast pain, swelling, asymmetry, wrinkling/rippling, implant malposition nipple complications, hypertrophic scarring, and implant palpability/visibility.
Talk to your doctor about other complications.
For more information, see the patient brochures at www.allergan.com/products . To report a problem with Natrelle ® Breast Implants, please call Allergan ® at 1-800-624-4261.
The sale and distribution of Natrelle ® Breast Implants is restricted to licensed physicians who provide information to patients about the risks and benefits of breast implant surgery.
About Natrelle ® Natrelle ® offers a wide range of breast implant options designed with safety, science, and aesthetics in mind. Backed by over 600 published studies and more than 50 years of research and experience, Natrelle ® implants provide patients and surgeons with choices to support personalized outcomes.
About Allergan Aesthetics At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skincare, and more. With cutting-edge science and a deep understanding of patients, we are committed to empowering confidence.
Allergan Aesthetics Media: Ember Garrett +1 (949) 413-6091 [email protected]
AbbVie Investors: Liz Shea +1 (847) 935-2211 [email protected]